A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine

Headache

Volumn 42, Issue 1, 2002, Pages 32-40

  Mathew, Ninan T ^a  

^a Houston Headache Clinic   (United States)

Author keywords

Almotriptan; Headache; Migraine; Open label; Triptans

Indexed keywords

ALMOTRIPTAN;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGEAL ARTERY; MIGRAINE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; VERTIGO;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDOLES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN AGONISTS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 0036166346     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02011.x     Document Type: Article

References (25)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
2. Prevalence and impact of migraine
3. Migraine prevalence. A review of population-based studies
4. Migraine
5. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors
6. Pathophysiology of migraine - New insights
7. Serotonin receptors and the acute attack of migraine
8. Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: Recent findings in animals
9. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
10. Acute management of migraine: Triptans and beyond
11. Current and emerging second-generation triptans in acute migraine therapy: A comparative review
12. Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients
13. Adverse reactions attributed to sumatriptan. A postmarketing study in general practice
14. Chest symptoms after sumatriptan: A two-year clinical practice review in 735 consecutive migraine patients
15. Pharmacological characterization of almotriptan: An indolic 5-HT receptor agonist for the treatment of migraine
16. 1D agonist
17. Oral almotriptan in the treatment of migraine A dose finding study
18. 1B/1D agonist, compared with sumatriptan 100 mg
19. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: Results of a large, randomized, double-blind, placebo-controlled study
20. Guidelines for controlled trials of drugs in migraine
21. Long-term efficacy and safety of oral almotriptan: Interim analysis of a 1-year open study
22. Zolmitriptan: A review of its use in migraine
23. Rizatriptan: A review of its efficacy in the management of migraine
24. Vasospasminduced myocardial infarction with sumatriptan
25. Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers